Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05274165 · ClinicalTrials.gov registry record · NA
Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology
A NA study, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05274165: Completed NA study, sponsored by Sonova.
NCT05274165 is a NA study that has completed, run by Sonova. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05274165, a NA study, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Two groups of hearing aid candidates will be fit with extended wear technology. One group will be fit with the commercially available models, and the other group will be fit with either the commercially available model or a new model with different fitting characteristic. After an appropriate trial period, the success rate of each group will be determined by the desire to purchase devices.
Primary Outcome
Percentage of participants who express intent to purchase devices at end of study trial period. No statistical analysis was performed on this outcome measure.
Interventions
- DEVICE Lyric Hearing Aid- Experimental Design
- DEVICE Lyric Hearing Aid- Commercially Available
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-03-29 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT05274165 record still lists
NCT05274165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Lyric Hearing Aid- Experimental Design is the first listed.
NCT05274165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05274165 about?
NCT05274165 is a clinical study titled "Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology". Two groups of hearing aid candidates will be fit with extended wear technology. One group will be fit with the commercially available models, and the other group will be fit with either the commercially available model or a new model with different fitting characteristic. After an appropriate trial...
What is the current status of trial NCT05274165?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-03-29. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT05274165?
The interventions under investigation include: Lyric Hearing Aid- Experimental Design (DEVICE), Lyric Hearing Aid- Commercially Available (DEVICE).
Who is sponsoring clinical trial NCT05274165?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05274165's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI